Literature DB >> 15987315

Intralesional tuberculin for treatment of refractory warts.

S Kus, T Ergun, D Gun, O Akin.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15987315     DOI： 10.1111/j.1468-3083.2004.01176.x

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN： 0926-9959            Impact factor:   6.166


× No keyword cloud information.
  10 in total

1.  An Intention-to-Treat-Analysis of the Efficacy of Immunotherapy Using Mycobacterium W Vaccine and Purified Protein Derivative of Tuberculin for Warts With Assessment of Improvement in Quality of Life.

Authors:  Alpana Mohta; Manoj Kumar Sharma; Pramila Kumari; Bhikam Chand Ghiya; Rajesh Dutt Mehta
Journal:  Dermatol Pract Concept       Date:  2022-04-01

2.  Study of BCG Immunotherapy in the Management of Multiple, Extensive Non-Genital Cutaneous Common Warts.

Authors:  Angoori Gnaneshwar Rao; Ruhi Haqqani
Journal:  Indian Dermatol Online J       Date:  2020-09-19

3.  Intralesional Purified Protein Derivative of Tuberculin Versus Intralesional Mycobacterium W Vaccine in Treatment of Recalcitrant Extragenital Warts: A Randomized, Single-Blinded, Comparative Study.

Authors:  Alpana Mohta; Suresh Kumar Jain; Rajesh Dutt Mehta; Aakanksha Arora
Journal:  Indian J Dermatol       Date:  2022 Jan-Feb       Impact factor: 1.757

Review 4.  Immunomodulators in warts: Unexplored or ineffective?

Authors:  Surabhi Sinha; Vineet Relhan; Vijay K Garg
Journal:  Indian J Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.494

5.  Intralesional immunotherapy for difficult to treat warts with Mycobacterium w vaccine.

Authors:  Shilpa Garg; Sukriti Baveja
Journal:  J Cutan Aesthet Surg       Date:  2014 Oct-Dec

6.  Success of Intralesional Purified Protein Derivative Immunotherapy in the Treatment of Anogenital Warts: A Case Report.

Authors:  Pati Aji Achdiat; Narizka Civiadenta Antariksa; Rasmia Rowawi; Oki Suwarsa; Yudi Mulyana Hidayat; Reiva Farah Dwiyana; Hendra Gunawan; Reti Hindritiani
Journal:  J Exp Pharmacol       Date:  2022-04-04

7.  Comparative Study of Efficacy of Intralesional Purified Protein Derivative (PPD) Versus Intralesional Measles, Mumps, and Rubella (MMR) Vaccine in Management of Multiple Viral Warts.

Authors:  Krishna B Bhalala; Shital Poojary; Kapisha Sunny Shah
Journal:  J Cutan Aesthet Surg       Date:  2021 Oct-Dec

8.  Intralesional Injection of the Measles-Mumps-Rubella Vaccine into Resistant Palmoplantar Warts: A Randomized Controlled Trial.

Authors:  Mohammad Sadegh Rezai; Hiva Ghasempouri; Ozra Asqary Marzidareh; Jamshid Yazdani Cherati; Ghasem Rahmatpour Rokni
Journal:  Iran J Med Sci       Date:  2019-01

9.  A Randomized double Blind Controlled Study Comparing the Efficacy of Intralesional MMR Vaccine with Normal Saline in the Treatment of Cutaneous Warts.

Authors:  Chesta Agrawal; Kapil Vyas; Asit Mittal; Ashok K Khare; Lalit K Gupta
Journal:  Indian Dermatol Online J       Date:  2018 Nov-Dec

10.  A Randomized Comparative Study of MIP and MMR Vaccine for the Treatment of Cutaneous Warts.

Authors:  Amandeep Kaur; Balvinder Kaur Brar; Sumir Kumar; Sukhmani Kaur Brar; Amarbir Singh Boparai; Neerja Puri
Journal:  Indian J Dermatol       Date:  2021 Mar-Apr       Impact factor: 1.494
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.